18.98
3.66%
0.67
Handel nachbörslich:
19.00
0.02
+0.11%
Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
18.99%
0.213
|
0.179 | 0.265 | -0.027 | 0.584 |
Operating Expenses
|
17.07%
42.60
|
36.39 | 20.76 | 15.77 | 537.74 |
Benefits Costs and Expenses |
18.89%
43.69
|
36.75 | 21.53 | 14.69 | 542.96 |
Costs And Expenses |
17.07%
42.60
|
36.39 | 20.76 | 15.77 | 537.74 |
Operating Income/Loss |
17.06%
-42.39
|
-36.21 | -20.49 | -15.79 | -537.15 |
Nonoperating Income/Loss |
203.64%
-1.084
|
-0.357 | -0.776 | 1.077 | -5.222 |
Income/Loss From Continuing Operations Before Tax |
18.89%
-43.47
|
-36.57 | -21.27 | -14.72 | -542.38 |
Income/Loss From Continuing Operations After Tax |
18.89%
-43.47
|
-36.57 | -21.27 | -14.72 | -542.38 |
Net Income/Loss
|
18.89%
-43.47
|
-36.57 | -21.27 | -14.72 | -542.38 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,473%
701.79
|
27.28 | 697.74 | 697.69 | 378.16 |
Diluted Average Shares |
2,473%
701.79
|
27.28 | 697.74 | 697.69 | 378.16 |
Basic Earnings Per Share |
500.00%
-0.06
|
-0.01 | -0.03 | -0.02 | -1.43 |
Diluted Earnings Per Share |
500.00%
-0.06
|
-0.01 | -0.03 | -0.02 | -1.43 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):